Senores Pharmaceuticals - SENORES, 544319 corporate action history

Senores Pharmaceuticals Ltd. NSE: SENORES | BSE: 544319

Mid-range Performer

Download real time

784.55 -21.40 (-2.66%)

78.19% Gain from 52W Low

1.3M

NSE+BSE Volume

High volume today

NSE 20 Jan, 2026 3:31 PM (IST)

Estimates Beat

Senores Pharma's Q3 profit and revenue beat Forecaster estimates by 12.2% and 2.9%, respectively See details

Senores Pharmaceuticals Bonus history

Senores Pharmaceuticals has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Senores Pharmaceuticals Split history

Senores Pharmaceuticals has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Senores Pharmaceuticals Dividend history

Senores Pharmaceuticals has not given any dividends since Jan 1, 2000.

See all forthcoming dividends

Board Meetings - Senores Pharmaceuticals

The latest board meeting for Senores Pharmaceuticals took place on 20 Jan 2026, for the purpose of Quarterly Results & Others

Ex-Date	Purpose	Notes
20 Jan 2026	Quarterly Results & Others	To consider other business matters.
07 Jan 2026	Others	Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group.
06 Nov 2025	Quarterly Results	-
23 Jul 2025	Quarterly Results & Others	To consider other business matters.
15 May 2025	Audited Results	-
23 Jan 2025	Quarterly Results & Others	To consider other business matters.

See all Board Meetings for Senores Pharmaceuticals

Senores Pharmaceuticals Rights history

Senores Pharmaceuticals has not issued any rights since Jan 1, 2000.

See all Rights History for Senores Pharmaceuticals